MEDP Medpace Holdings Inc

Price (delayed)

$183.995

Market cap

$6.59B

P/E Ratio

37.47

Dividend/share

N/A

EPS

$4.91

Enterprise value

$6.36B

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace's mission is to accelerate ...

Highlights
The EPS has soared by 65% YoY and by 10% QoQ
The net income has soared by 64% YoY and by 10% from the previous quarter
Medpace Holdings's quick ratio has increased by 25% YoY but it has decreased by 3.6% QoQ
The P/E is 22% lower than the 5-year quarterly average of 48.4 but 8% higher than the last 4 quarters average of 34.8

Key stats

What are the main financial stats of MEDP
Market
Shares outstanding
35.82M
Market cap
$6.59B
Enterprise value
$6.36B
Valuations
Price to earnings (P/E)
37.47
Price to book (P/B)
7.77
Price to sales (P/S)
6.42
EV/EBIT
32.98
EV/EBITDA
27.76
EV/Sales
6.19
Earnings
Revenue
$1.03B
EBIT
$192.97M
EBITDA
$229.25M
Free cash flow
$256.37M
Per share
EPS
$4.91
Free cash flow per share
$7.14
Book value per share
$23.68
Revenue per share
$28.65
TBVPS
$21.27
Balance sheet
Total assets
$1.47B
Total liabilities
$617.83M
Debt
$112.85M
Equity
$851.88M
Working capital
$77.49M
Liquidity
Debt to equity
0.13
Current ratio
1.16
Quick ratio
1.06
Net debt/EBITDA
-0.99
Margins
EBITDA margin
22.3%
Gross margin
30.2%
Net margin
17.1%
Operating margin
18.6%
Efficiency
Return on assets
12.5%
Return on equity
21.2%
Return on invested capital
227.2%
Return on capital employed
19.4%
Return on sales
18.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

MEDP stock price

How has the Medpace Holdings stock price performed over time
Intraday
-0.41%
1 week
-4.02%
1 month
2.53%
1 year
57.96%
YTD
32.18%
QTD
4.17%

Financial performance

How have Medpace Holdings's revenue and profit performed over time
Revenue
$1.03B
Gross profit
$310.09M
Operating income
$191.46M
Net income
$175.57M
Gross margin
30.2%
Net margin
17.1%
The net income has soared by 64% YoY and by 10% from the previous quarter
The operating income has increased by 45% year-on-year and by 7% since the previous quarter
The net margin is up by 41% year-on-year and by 2.4% since the previous quarter
MEDP's gross profit is up by 25% year-on-year and by 6% since the previous quarter

Growth

What is Medpace Holdings's growth rate over time

Valuation

What is Medpace Holdings stock price valuation
P/E
37.47
P/B
7.77
P/S
6.42
EV/EBIT
32.98
EV/EBITDA
27.76
EV/Sales
6.19
The EPS has soared by 65% YoY and by 10% QoQ
The P/E is 22% lower than the 5-year quarterly average of 48.4 but 8% higher than the last 4 quarters average of 34.8
MEDP's price to book (P/B) is 111% higher than its 5-year quarterly average of 3.7 and 22% higher than its last 4 quarters average of 6.4
Medpace Holdings's equity has increased by 15% YoY
MEDP's price to sales (P/S) is 84% more than its 5-year quarterly average of 3.5 and 17% more than its last 4 quarters average of 5.5
MEDP's revenue is up by 17% year-on-year and by 8% since the previous quarter

Efficiency

How efficient is Medpace Holdings business performance
MEDP's ROIC is down by 45% YoY but it is up by 26% QoQ
The company's return on equity rose by 42% YoY and by 6% QoQ
Medpace Holdings's return on assets has increased by 34% YoY and by 5% QoQ
The ROS is up by 25% YoY

Dividends

What is MEDP's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MEDP.

Financial health

How did Medpace Holdings financials performed over time
The company's total assets is 138% higher than its total liabilities
The total liabilities has grown by 28% YoY and by 4.3% from the previous quarter
Medpace Holdings's quick ratio has increased by 25% YoY but it has decreased by 3.6% QoQ
The debt is 87% smaller than the equity
MEDP's debt to equity is down by 19% year-on-year
Medpace Holdings's equity has increased by 15% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.